RecruitingNCT06802016

A Study of Chinese Congenital Bicuspid Aortic Valve

A Cohort Study of Congenital Bicuspid Aortic Valve

Sponsor

Ruijin Hospital

Enrollment

500 participants

Start Date

Jan 18, 2025

Study Type

OBSERVATIONAL

Conditions

Bicuspid Aortic Valve (BAV)

Summary

Pervious studies indicated that the prevalence of bicuspid aortic valve（BAV） might be higher in China. There is a familial predisposition to the development of BAV. The study analyzed epidemiological data on selected BAV and established a BAV cohort to observe disease progression and treatment outcomes.

Eligibility

Min Age: 14 YearsMax Age: 60 Years

Inclusion Criteria3

The patients were aged 14-60 years;
Definitive diagnosis of BAV by imaging (echocardiography, aortic CTA, cardiac magnetic resonance, etc.)
Patients were informed about the nature of the study and agreed to participate in all the terms of the study and signed an informed consent form approved by the ethics committee.

Exclusion Criteria4

Poor patient compliance and inability to complete follow-up visits as required;
Rheumatic heart valve disease, other organic valve disease.
Hyperthyroidism, severe anemia, and other factors that significantly affect hemodynamics.
Other circumstances that the researcher believes should be excluded.

Interested in this trial?

Get notified about updates and connect with the research team.